Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

New on Charts:

We've added Splits, Dividends, Earnings, and Earnings Estimates! Click on individual events to unveil more details.

If you prefer a cleaner view, easily disable them in Settings.

QLGN | Qualigen Therapeutics Inc

Index- P/E- EPS (ttm)-3.94 Insider Own11.58% Shs Outstand5.05M Perf Week-4.63%
Market Cap5.01M Forward P/E- EPS next Y-1.73 Insider Trans0.00% Shs Float4.47M Perf Month-1.80%
Income-17.51M PEG- EPS next Q-0.92 Inst Own1.50% Short Float / Ratio0.80% / 1.37 Perf Quarter4.40%
Sales6.07M P/S0.83 EPS this Y32.16% Inst Trans1.77% Short Interest0.04M Perf Half Y8.17%
Book/sh0.40 P/B2.46 EPS next Y47.42% ROA-88.65% Target Price65.00 Perf Year-62.85%
Cash/sh0.27 P/C3.74 EPS next 5Y- ROE-212.11% 52W Range0.83 - 3.24 Perf YTD-23.06%
Dividend- P/FCF- EPS past 5Y75.13% ROI-546.65% 52W High-69.39% Beta-0.55
Dividend %- Quick Ratio0.39 Sales past 5Y-11.85% Gross Margin23.24% 52W Low19.49% ATR0.06
Employees38 Current Ratio0.57 Sales Q/Q13.74% Oper. Margin-264.40% RSI (14)47.34 Volatility6.65% 5.49%
OptionableNo Debt/Eq1.58 EPS Q/Q39.01% Profit Margin-288.66% Rel Volume0.31 Prev Close1.03
ShortableYes LT Debt/Eq0.58 EarningsAug 15 BMO Payout- Avg Volume26.17K Price0.99
Recom1.00 SMA20-1.03% SMA50-5.15% SMA200-8.26% Volume8,124 Change-3.71%
Sep-27-23 08:30AM
Aug-30-23 07:09AM
Aug-17-23 08:30AM
Aug-15-23 08:30AM
Aug-01-23 08:30AM
08:15AM Loading…
Jul-24-23 08:15AM
Jun-14-23 10:30AM
Jun-05-23 08:15AM
May-16-23 08:00AM
May-12-23 07:20AM
May-02-23 04:30PM
Apr-21-23 05:46PM
Apr-18-23 08:45AM
08:35AM Loading…
Mar-21-23 08:35AM
Mar-15-23 09:05AM
Mar-09-23 08:30AM
Mar-08-23 08:05AM
Feb-01-23 09:05AM
Jan-24-23 09:00AM
Jan-23-23 09:02AM
Jan-10-23 09:00AM
Jan-05-23 09:00AM
Dec-12-22 08:30AM
Dec-07-22 09:10AM
Dec-01-22 07:11AM
Nov-22-22 09:00AM
Nov-17-22 06:12AM
Nov-15-22 07:30AM
09:00AM Loading…
Oct-19-22 09:00AM
Oct-18-22 09:00AM
Oct-06-22 08:00AM
Sep-14-22 05:02PM
Aug-25-22 06:45AM
Aug-18-22 09:15AM
Aug-16-22 07:30AM
Aug-01-22 08:30AM
Jul-06-22 09:00AM
Jun-14-22 09:00AM
Jun-07-22 09:04AM
Jun-06-22 06:10AM
Jun-02-22 09:00AM
May-26-22 09:15AM
May-20-22 09:15AM
May-13-22 06:00AM
May-10-22 09:17AM
May-03-22 02:24PM
Apr-29-22 09:15AM
Apr-18-22 06:25AM
Apr-12-22 10:15AM
Apr-05-22 09:15AM
Apr-01-22 08:00AM
Mar-30-22 09:15AM
Mar-22-22 09:15AM
Mar-15-22 09:15AM
Feb-22-22 09:15AM
Feb-15-22 09:15AM
Feb-01-22 09:15AM
Jan-18-22 09:15AM
Dec-14-21 09:18AM
Dec-01-21 03:25PM
Nov-29-21 03:50PM
Nov-22-21 10:23AM
Nov-15-21 09:00AM
Oct-19-21 09:00AM
Sep-15-21 07:30AM
Sep-08-21 07:30AM
Aug-31-21 06:22AM
Aug-23-21 09:58AM
Aug-17-21 10:01AM
Jul-14-21 07:30AM
Jul-07-21 10:37AM
Jun-08-21 07:30AM
Jun-02-21 07:30AM
May-19-21 07:30AM
May-18-21 02:10PM
May-14-21 01:35PM
Apr-26-21 07:00AM
Apr-19-21 01:16PM
Apr-06-21 09:30AM
Mar-18-21 08:30AM
Mar-09-21 08:30AM
Mar-08-21 08:30AM
Mar-01-21 08:30AM
Jan-26-21 09:00AM
Dec-30-20 11:16AM
Dec-22-20 09:00AM
Dec-18-20 03:07PM
Dec-16-20 10:25AM
Dec-15-20 09:00AM
Dec-08-20 09:00AM
Dec-02-20 09:00AM
Nov-30-20 09:40AM
Qualigen Therapeutics, Inc. is a biotechnology company focused on developing therapeutics for the treatment of cancer and infectious diseases. The company's cancer therapeutics pipeline includes ALAN (AS1411-GNP), RAS-F3 and STARS. ALAN (AS1411-GNP) is a DNA coated gold nanoparticle cancer drug candidate that has the potential to target various types of cancer with minimal side effects. RAS-F3 is a small molecule RAS oncogene protein-protein inhibitor for blocking RAS mutations that lead to tumor formation, especially in pancreatic, colorectal and lung cancers. STARS is a DNA/RNA-based treatment device for removal from circulating blood of precisely targeted tumor-produced and viral compounds. The company was founded on March 29, 2004 and is headquartered in Carlsbad, CA.